BD2797645
FatostatinHydrobromide , 98% , 298197-04-3
Synonym(s):
125B11, 2-Propyl-4-(4-(p-tolyl)thiazol-2-yl)pyridine, HBr, SREBP Processing Inhibitor II;25B11 hydrobromide;4-[4-(4-methylphenyl)-2-thiazolyl]-2-propylpyridine hydrobromide;Fatostatin - CAS 298197-04-3 - Calbiochem;Fatostatin A hydrobromide; 2-(2-propylpyridin-4-yl)-4-p-tolylthiazole hydrobromide
| Pack Size | Price | Stock | Quantity |
| 50mg | RMB774.40 | In Stock |
|
| 100mg | RMB1238.40 | In Stock |
|
| 250mg | RMB2104.80 | In Stock |
|
| 1g | RMB5682.40 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| storage temp. | 2-8°C |
| solubility | DMSO: ≥10mg/mL |
| form | powder |
| color | light yellow to yellow |
| InChI | 1S/C18H18N2S.BrH/c1-3-4-16-11-15(9-10-19-16)18-20-17(12-21-18)14-7-5-13(2)6-8-14;/h5-12H,3-4H2,1-2H3;1H |
| InChIKey | RJCFNQZVFUMORB-UHFFFAOYSA-N |
| SMILES | [s]1c(nc(c1)c3ccc(cc3)C)c2cc(ncc2)CCC.Br |
Description and Uses
Fatostatin hydrobromide has been used:
- to study its anti-cancer activity and effects on mitotic microtubule spindle
- to study its effects on stomatal development
- to prevent SREBP cleavage-activating protein (SCAP)-mediated escort of sterol regulatory element-binding proteins (SREBPs)
Safety
| Symbol(GHS) |  GHS07 |
| Signal word | Warning |
| Hazard statements | H302-H315-H319-H335 |
| Precautionary statements | P261-P305+P351+P338 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| WGK Germany | 1 |
| Storage Class | 11 - Combustible Solids |
